Home > Healthcare > Medical Devices > Therapeutic Devices > Femtech Market
The global femtech market size was valued at around USD 55.1 billion in 2023 and is estimated to grow at 12.8% CAGR from 2024 to 2032. The increasing burden of chronic and infectious diseases among the female population is driving growth in the market.
The rising prevalence of chronic conditions such as cancer, diabetes, hypertension, and mental health disorders, along with infectious diseases including HIV and tuberculosis, disproportionately affects women. This escalating burden underscores the urgent need for effective solutions to manage and mitigate these health issues. For instance, in 2022, the World Health Organization reported 2.3 million new breast cancer diagnoses and 670,000 deaths globally.
Femtech offers personalized and targeted tools to address these complex challenges, highlighting the need for innovative technology in tackling significant health concerns. Similarly, women are increasingly affected by conditions such as diabetes, hypertension, and cardiovascular diseases, which necessitate continuous management and monitoring. Limited access to healthcare resources, particularly in underserved regions, exacerbates these challenges.
Femtech, also referred to as female technology, encompasses a wide range of products, services, and software designed to address women's health concerns. This technology-driven industry focuses on various aspects of women’s health, including fertility solutions, pregnancy and nursing care, reproductive health, and overall wellness.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Femtech Market Size in 2023: | USD 55.1 Billion |
Forecast Period: | 2024 - 2032 |
Forecast Period 2024 - 2032 CAGR: | 12.8% |
2032 Value Projection: | USD 135.9 Billion |
Historical Data for: | 2021-2023 |
No. of Pages: | 131 |
Tables, Charts & Figures: | 294 |
Segments covered: | Type, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|